Aller au contenu principal
Accès ouvert déclaré 2024 article

Contrast-Enhanced CISS/FIESTA Imaging for Increased Conspicuity of Pituitary Microadenomas in Cushing Disease

4Citations signalées, ce qui n’est pas une note de qualité
3Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : us. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

ABSTRACT Background and Purpose: Pituitary microadenomas can be challenging to see on MRI, particularly when they are small. The detection of microadenomas commonly relies on contrast-enhanced sequences, highlighting the adenoma that demonstrates hypoenhancement relative to the native pituitary on T1-weighted sequences. Detecting adenomas in patients with Cushing disease is crucial, as surgery is the standard of care treatment. Accurate pre-operative lesion localization is directly associated with improved outcomes. The purpose of our study was to determine the utility of contrast-enhanced CISS/FIESTA-C for identifying pituitary microadenomas in patients with Cushing disease. Materials and Methods: This cross-sectional study retrospectively reviewed pituitary MR images in patients with Cushing disease who had post-contrast CISS/FIESTA-C. Images were evaluated for lesion conspicuity (well-defined margins), as well as the signal intensity of the adenoma and native pituitary. The normalized signal intensity difference (nSID) was calculated by subtracting the lesion signal intensity from the pituitary signal intensity, and dividing by the pituitary signal intensity. Patient age, sex, and diagnosis based on intraoperative findings, pathology results, and post-operative adrenal insufficiency were recorded. Results: 17 patients (15 female) were included in this study. 16 (94%) adenomas were discrete on CISS/FIESTA-C compared to 11 (65%) on T1-weighted imaging. The mean adenoma nSID with CISS/FIESTA-C was 0.512 (SD 0.12), relative to 0.242 (SD 0.15) on T1-weighted imaging (p<0.001). Conclusion: In comparison to MRI T1-weighted images, contrast-enhanced CISS/FIESTA-C imaging detects a higher number of pituitary microadenomas with superior conspicuity. As up to 50% of patients with Cushing disease present without a pituitary lesion detect on MRI, post contrast CISS/FIESTA-C may be especially valuable as an additional sequence in this population. ABBREVIATIONS: CISS = Constructive interference in steady state; FIESTA-C = fast imaging employing steady-state acquisition with cycling; SI = Signal Intensity, nSID = normalized signal intensity difference

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Contrast-Enhanced CISS/FIESTA Imaging for Increased Conspicuity of Pituitary Microadenomas in Cushing Disease
Date Crossref
21/11/2024
Éditeur
American Society of Neuroradiology (ASNR)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Pituitary Gland Disorders and TreatmentsGrowth Hormone and Insulin-like Growth FactorsMyasthenia Gravis and Thymoma

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.